Increased risk for coronary heart disease after avascular necrosis of femoral head: A 3-year follow-up study

American Heart Journal

Volumn 159, Issue 5, 2010, Pages

  Kang, Jiunn Horng ^a,b   Lin, Herng Ching ^c  

^a TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; AVASCULAR NECROSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; FEMUR HEAD NECROSIS; FOLLOW UP; GENDER; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

EID: 77951569360     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.02.020     Document Type: Article

References (29)

1. Pavelka K. Osteonecrosis. Baillieres Best Pract Res Clin Rheumatol 14 (2000) 399-414
2. Lafforgue P. Pathophysiology and natural history of avascular necrosis of bone. Joint Bone Spine 73 (2006) 500-507
3. Assouline-Dayan Y., Chang C., Greenspan A., et al. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 32 (2002) 94-124
4. Malizos K.N., Karantanas A.H., Varitimidis S.E., et al. Osteonecrosis of the femoral head: etiology, imaging and treatment. Eur J Radiol 63 (2007) 16-28
5. Kerachian M.A., Harvey E.J., Cournoyer D., et al. Avascular necrosis of the femoral head: vascular hypotheses. Endothelium 13 (2006) 237-244
6. Boss J.H., and Misselevich I. Osteonecrosis of the femoral head of laboratory animals: the lessons learned from a comparative study of osteonecrosis in man and experimental animals. Vet Pathol 40 (2003) 345-354
7. Glueck C.J., Freiberg R.A., Fontaine R.N., et al. Hypofibrinolysis, thrombophilia, osteonecrosis. Clin Orthop Relat Res (2001) 19-33
8. Glueck C.J., Freiberg R.A., and Wang P. Role of thrombosis in osteonecrosis. Curr Hematol Rep 2 (2003) 417-422
9. Jones L.C., Mont M.A., Le T.B., et al. Procoagulants and osteonecrosis. J Rheumatol 30 (2003) 783-791
10. Almeida M.M. The role of protein C deficiency in the etiology of Perthes disease. Ortop Traumatol Rehabil 10 (2008) 274-278
11. Wenstrup R.J., Roca-Espiau M., Weinreb N.J., et al. Skeletal aspects of Gaucher disease: a review. Br J Radiol 75 (2002) A2-A12
12. bu-Shakra M., Buskila D., and Shoenfeld Y. Osteonecrosis in patients with SLE. Clin Rev Allergy Immunol 25 (2003) 13-24
13. Aguilar C., Vichinsky E., and Neumayr L. Bone and joint disease in sickle cell disease. Hematol Oncol Clin North Am 19 (2005) 929-941
14. Morse C.G., Mican J.M., Jones E.C., et al. The incidence and natural history of osteonecrosis in HIV-infected adults. Clin Infect Dis 44 (2007) 739-748
15. Orban H., Cirstoiu C., and Adam R. Total hip arthroplasty in secondary systemic lupus erythematosus femoral head avascular necrosis. Rom J Intern Med 45 (2007) 123-129
16. Rueda J.C., Duque M.A., Mantilla R.D., et al. Osteonecrosis and antiphospholipid syndrome. J Clin Rheumatol 15 (2009) 130-132
17. Glueck C.J., Freiberg R.A., Oghene J., et al. Association between the T-786C eNOS polymorphism and idiopathic osteonecrosis of the head of the femur. J Bone Joint Surg Am 89 (2007) 2460-2468
18. Ameno K., Ameno S., Kinoshita H., et al. Autopsy and postmortem examination case study on genetic risk factors for cardiac death: polymorphisms of endothelial nitric oxide synthase gene Glu298Asp variant and T-786C mutation, human paraoxonase 1 (PON1) gene and alpha2beta-adrenergic receptor gene. Vojnosanit Pregl 63 (2006) 357-361 discussion 362-353
19. Suzuki S., Yoshimura M., Nakayama M., et al. A novel genetic marker for coronary spasm in women from a genome-wide single nucleotide polymorphism analysis. Pharmacogenet Genomics 17 (2007) 919-930
20. Seki T., Hasegawa Y., Masui T., et al. Quality of life following femoral osteotomy and total hip arthroplasty for nontraumatic osteonecrosis of the femoral head. J Orthop Sci 13 (2008) 116-121
21. Holmes S.D., Krantz D.S., Rogers H., et al. Mental stress and coronary artery disease: a multidisciplinary guide. Prog Cardiovasc Dis 49 (2006) 106-122
22. Buttar H.S., Li T., and Ravi N. Prevention of cardiovascular diseases: role of exercise, dietary interventions, obesity and smoking cessation. Exp Clin Cardiol 10 (2005) 229-249
23. Wannamethee S.G., and Shaper A.G. Physical activity in the prevention of cardiovascular disease: an epidemiological perspective. Sports Med 31 (2001) 101-114
24. Hermann M., and Ruschitzka F. Coxibs, non-steroidal anti-inflammatory drugs and cardiovascular risk. Intern Med J 36 (2006) 308-319
25. Walker B.R. Glucocorticoids and cardiovascular disease. Eur J Endocrinol 157 (2007) 545-559
26. Kim C., Redberg R.F., Pavlic T., et al. A systematic review of gender differences in mortality after coronary artery bypass graft surgery and percutaneous coronary interventions. Clin Cardiol 30 (2007) 491-495
27. Motovska Z., Widimsky P., and Aschermann M. The impact of gender on outcomes of patients with ST elevation myocardial infarction transported for percutaneous coronary intervention: analysis of the PRAGUE-1 and 2 studies. Heart 94 (2008) e5
28. Singh M., Rihal C.S., Gersh B.J., et al. Mortality differences between men and women after percutaneous coronary interventions. A 25-year, single-center experience. J Am Coll Cardiol 51 (2008) 2313-2320
29. Blankstein R., Ward R.P., Arnsdorf M., et al. Female gender is an independent predictor of operative mortality after coronary artery bypass graft surgery: contemporary analysis of 31 Midwestern hospitals. Circulation 112 (2005) I323-I327